Viewing Study NCT00496119



Ignite Creation Date: 2024-05-05 @ 6:32 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00496119
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-20
First Post: 2007-07-02

Brief Title: Proton Beam Therapy for Chordoma Patients
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Study Overview

Official Title: Phase II Evaluation of Proton Beam Therapy for Skull Base Chordoma
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical research study is to learn if proton beam therapy with or without photon beam radiation therapy is effective in the treatment of skull base chordoma The safety of this treatment will also be studied
Detailed Description: Proton therapy is a kind of external beam radiation therapy where protons are directed to a tumor site Researchers are trying to determine what level of proton therapy gives the most benefit without causing toxic side effects Researchers will also be testing the treatments effect

If your doctor feels it is necessary the proton beam therapy may be combined with standard photon therapy

If you are eligible to take part in this study you will receive proton beam therapy at The University of Texas UT MD Anderson Cancer Center MDACC and possibly photon beam no sooner than 2 weeks after the last surgery to remove the tumor You will receive proton beam therapy once a day for about 35 treatments 7 weeks Treatment will be given for 5 days in a row each week except for Saturdays Sundays and holidays at the MDACC Proton Center in Houston The whole process should take up to 1 hour each day

This is an investigational study The proton beam machine used to deliver treatment is approved by the FDA for patient use The doses being studied are experimental About 15 participants will take part in this study All will be enrolled at MDACC

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
NCI-2012-01509 REGISTRY NCI CTRP None